Skip to content
POM-V Prescription Required Companion Animal

Dermipred 20 mg Tablets for Dogs

Active ingredient: Prednisolone

Form

Tablet

Species

Dogs

Manufacturer

Ceva Sante Animale

VMD MA No.

14966/3080

What it's used for

Streptococci (including S. uberis). Escherichia coli (including β-lactamase producing strains). AN: 01491/2024 & 01490/2024

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Prednisolone

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Dermipred 20 mg Tablets for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Streptococci (including S. uberis).
Escherichia coli (including β-lactamase producing strains).
AN: 01491/2024 & 01490/2024
The syringe must only be used once. Partly emptied syringes due to the
unsuccessful use should be discarded.
AN: 01491/2024 & 01490/2024
The content of one syringe should be infused gently into the teat of the infected
quarter every 12 hours after each of three consecutive milkings.
Milk out the infected quarters. After thoroughly cleaning and disinfecting the teat and
teat orifice with the cleaning towels provided, gently infuse the contents of one
syringe into each affected quarter. Disperse the veterinary medicinal product by
gentle massage of the teat and udder of the affected animal.
In cases of infections caused by Staphylococcus aureus, a longer course of
antibacterial therapy may be required. Therefore overall treatment length must be at
the veterinarian’s discretion but should be long enough to ensure complete resolution
of intramammary infection.
Combined therapy for the treatment of bovine mastitis. In the situation where
systemic treatment as well as intramammary treatment is necessary, especially in
cases of serious clinical mastitis Combiclav Injection can be administered in
combination with this product.
For combined therapy the following minimum treatment regime should be followed:
Potentiated Penicillin InjectionPotentiated Penicillin Intramammary
Suspension for Lactating Cows
Intramuscular injection at a dose rate of
8.75 mg/kg bodyweight (7,0 amoxicillin
and 1,75 mg clavulanic acid) which
corresponds to 1 mL of veterinary
medicinal product/20 kg bodyweight
daily for 3 days as follows:
8.75 mg/kg bodyweight (7.0 mg
amoxicillin, 1.75 mg clavulanic acid) i.e.
1 mL/20 kg bodyweight
24 hours
8.75 mg/kg bodyweight (7.0 mg
amoxicillin, 1.75 mg clavulanic acid) i.e.
1 mL/20 kg bodyweight
24 hours
8.75 mg/kg bodyweight (7.0 mg
amoxicillin, 1.75 mg clavulanic acid) i.e.
1 mL/20 kg bodyweight
Where necessary Potentiated Penicillin
Injection may be administered for an
additional two days for a total of 5 daily
injections
The content of one syringe should be
infused gently into the teat of the
infected quarter every 12 hours after
each of three consecutive milkings as
follows:
One syringe gently infused into the teat
of the infected quarter
12 hours
One syringe gently infused into the teat
of the infected quarter
12 hours
One syringe gently infused into the teat
of the infected quarter
AN: 01491/2024 & 01490/2024
Do not use in animals with:
- Viral, mycotic or parasitic infections that are not controlled with an
appropriate treatment
- Diabetes mellitus
- Hyperadrenocorticism
- Osteoporosis
- Heart failure
- Severe renal insufficiency
AN: 02375/2025Page 2 of 7
- Corneal ulceration
- Gastro-intestinal ulceration
- Glaucoma
Do not use concomitantly with attenuated live vaccines.
Do not use in known cases of hypersensitivity to the active substance, to other
corticosteroids, or to any of the excipients.
See also sections 3.7 and 3.8.
Dogs:
Very common
(>1 animal / 10 animals
treated):
Elevated triglyceride, hypocortisolaemia
Hypoadrenocorticism
Very rare
(<1 animal / 10,000
animals treated,
including isolated
reports):
Hyperadrenocorticism , Cushing’s disease ,
diabetes mellitus
Low thyroxine (T4), elevated liver enzymes, elevated serum alkaline
phosphatase (ALP), eosinopenia, lymphopenia, neutrophilia
Muscle wasting
Polyuria
Polydipsia
, polyphagia
Skin thinning
Gastrointestinal ulceration
, pancreatitis
Behavioural disorders,
Undetermined
frequency
(cannot be estimated
from the available data)
Elevated parathyroid (PTH) concentration, decreased lactate
dehydrogenase (LDH), decreased aspartate aminotransferase
(AST), hyperalbuminemia, hypernatraemia
, hypokalaemia
Muscle weakness, osteoporosis, inhibition of longitudinal growth of
bones
Increased weight, delayed healing, water retention, redistribution of
body fat
Opportunistic infection
Cutaneous calcinosis
is a consequence of the suppression of the hypothalamic-pituitary-adrenal axis.
Signs of adrenal insufficiency can arise following cessation of treatment, and this
may render the animal unable to deal adequately with stressful situations
particularly during the early stages of therapy
AN: 02375/2025Page 4 of 7
may be exacerbated by steroids in animals given non-steroidal anti-inflammatory
drugs and in animals with spinal cord trauma.
in case of long-term use.
the immunosuppressant action of corticosteroids may weaken resistance to
or exacerbate existing infections.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.
Glucocorticoids administration is to induce an improvement in clinical signs rather
than a cure. The treatment should be combined with treatment of the underlying
disease and/or environmental control.

Special precautions for safe use in the target species:
In cases where a bacterial infection is present the product should be used in
association with suitable antibacterial therapy. Pharmacologically-active dose
levels may result adrenal insufficiency. This may become apparent particularly after
withdrawal of corticosteroid treatment. This effect may be minimised by institution
of alternate-day therapy if practical. The dosage should be reduced and withdrawn
gradually to avoid precipitation of adrenal insufficiency (see section 3.9).
Corticoids such as prednisolone, exacerbate proteinaceous catabolism.
Consequently, the product should be carefully administered in old or malnourished
animals.
Corticoids such as prednisolone should be used with caution in patients with
hypertension, epilepsy, burns, previous steroid myopathy, in immunocompromised
animals and in young animals as corticosteroids may induce a delayed growth.
Treatment with the veterinary medicinal product may interfere with vaccination
efficacy. (See section 3.8)
Special monitoring is required in animals presenting with renal insufficiency. Use
only after careful benefit-risk assessment by the responsible veterinarian.
The tablets are flavoured. In order to avoid any accidental ingestion, store tablets out
of reach of the animals.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Prednisolone or other corticosteroids may cause hypersensitivity (allergic
reactions). People with known hypersensitivity to prednisolone or other
corticosteroids, or any of the excipients, should avoid contact with the veterinary
medicinal product.
To avoid accidental ingestion, particularly by a child, unused part-tablets should be
returned to the open blister space and inserted back into the carton. In case of
accidental ingestion, especially by a child, seek medical advice immediately and
show the package leaflet or the label to the physician.
AN: 02375/2025Page 3 of 7
Corticosteroids can cause foetal malformations; therefore it is recommended that
pregnant women avoid contact with the veterinary medicinal product. Immediately
wash hands thoroughly after handling the tablets.
Special precautions for the protection of the environment:
Not applicable.
None known.
Do not store above 25°C.
Any unused tablet portion should be returned to the blister and be used for the next
administration.
Not applicable
4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.